{"id":15101,"date":"2017-04-06T01:03:43","date_gmt":"2017-04-06T05:03:43","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=15101"},"modified":"2017-04-06T01:03:43","modified_gmt":"2017-04-06T05:03:43","slug":"robots-take-over-susanna-koelblin-linkedin","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/","title":{"rendered":"Robots Take Over | Susanna Koelblin | LinkedIn"},"content":{"rendered":"<p><a href=\"https:\/\/www.linkedin.com\/pulse\/robots-take-over-apparel-production-susanna-koelblin?trk=eml-email_feed_ecosystem_digest_01-hero-0-null&amp;midToken=AQFq7vtig2Z9eg&amp;fromEmail=fromEmail&amp;ut=25hYGdowAIiDI1\"><img data-recalc-dims=\"1\" decoding=\"async\" class=\"alignnone size-full\" src=\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg?w=525&#038;ssl=1\" alt=\"\" \/><\/a><\/p>\n<p>From Susanna Koelblin:<\/p>\n<p><strong>First large scale shoe robot factory unveiled: Adidas will use machines in Germany instead of humans in Asia to make shoes<\/strong><\/p>\n<blockquote><p>Adidas, the German maker of sportswear, has announced it will start marketing its first series of shoes manufactured by robots in Germany from 2017. More than 20 years after Adidas ceased production activities in Germany and moved them to Asia, Adidas unveiled the group\u2019s new prototype \u201cSpeedfactory\u201d in Germany. As of this year, the factory will begin large-scale production. What&#8217;s more, Adidas will also open a second Speedfactory in the U.S. in 2017, followed by more in Western Europe. According to the company, the German and American plants will in the &#8220;mid-term&#8221; each scale up to producing half a million pair of shoes per year.<\/p>\n<p>Does this pose a threat to Adidas&#8217;s traditional manufacturing base in China, Indonesia and Vietnam? After all, labor in the region is becoming less cheap these days, and manufacturers are increasingly turning to robots. The current model in the apparel industry is very much based on sourcing products from countries where consumers are typically not based. In the longer term Adidas could even produce the shirts of Germany\u2019s national football team in its home country. The shoes made in Germany would sell at a similar price to those produced in Asia, where Adidas employs around one million workers. Arch-rival Nike is also developing its robot-operated factory.<\/p>\n<p>This development in the shoe area is just the beginning and will be leveraged to the apparel industry as well&#8230;.<\/p><\/blockquote>\n<p>Robot factories will not restore former employment levels, with operations run by a skeleton staff. And low employment leads to low consumption. But new factories will require intensive capital investment. This may portend increased demand for capital in the future. With current high debt levels threatening the stability of the financial system, equity investors may be in short supply.<\/p>\n<p>Source: <a href=\"https:\/\/www.linkedin.com\/pulse\/robots-take-over-apparel-production-susanna-koelblin\">Robots Take Over \u2013 The Apparel Production | Susanna Koelblin | Pulse | LinkedIn<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>From Susanna Koelblin: First large scale shoe robot factory unveiled: Adidas will use machines in Germany instead of humans in Asia to make shoes Adidas, the German maker of sportswear, has announced it will start marketing its first series of shoes manufactured by robots in Germany from 2017. More than 20 years after Adidas ceased &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Robots Take Over | Susanna Koelblin | LinkedIn&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[46,29,33],"tags":[],"class_list":["post-15101","post","type-post","status-publish","format-standard","hentry","category-deficit-spending-employment","category-the-big-picture","category-uk-europe-countries-regions"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Robots Take Over | Susanna Koelblin | LinkedIn - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Robots Take Over | Susanna Koelblin | LinkedIn - the patient investor\" \/>\n<meta property=\"og:description\" content=\"From Susanna Koelblin: First large scale shoe robot factory unveiled: Adidas will use machines in Germany instead of humans in Asia to make shoes Adidas, the German maker of sportswear, has announced it will start marketing its first series of shoes manufactured by robots in Germany from 2017. More than 20 years after Adidas ceased &hellip; Continue reading &quot;Robots Take Over | Susanna Koelblin | LinkedIn&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2017-04-06T05:03:43+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"Robots Take Over | Susanna Koelblin | LinkedIn\",\"datePublished\":\"2017-04-06T05:03:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/\"},\"wordCount\":331,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg\",\"articleSection\":[\"Deficit Spending &amp; Employment\",\"The Big Picture\",\"UK &amp; Europe\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/\",\"name\":\"Robots Take Over | Susanna Koelblin | LinkedIn - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg\",\"datePublished\":\"2017-04-06T05:03:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg?fit=2000%2C1125&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg?fit=2000%2C1125&ssl=1\",\"width\":2000,\"height\":1125},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Robots Take Over | Susanna Koelblin | LinkedIn\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Robots Take Over | Susanna Koelblin | LinkedIn - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Robots Take Over | Susanna Koelblin | LinkedIn - the patient investor","og_description":"From Susanna Koelblin: First large scale shoe robot factory unveiled: Adidas will use machines in Germany instead of humans in Asia to make shoes Adidas, the German maker of sportswear, has announced it will start marketing its first series of shoes manufactured by robots in Germany from 2017. More than 20 years after Adidas ceased &hellip; Continue reading \"Robots Take Over | Susanna Koelblin | LinkedIn\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2017-04-06T05:03:43+00:00","og_image":[{"url":"http:\/\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg","type":"","width":"","height":""}],"author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"Robots Take Over | Susanna Koelblin | LinkedIn","datePublished":"2017-04-06T05:03:43+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/"},"wordCount":331,"commentCount":0,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#primaryimage"},"thumbnailUrl":"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg","articleSection":["Deficit Spending &amp; Employment","The Big Picture","UK &amp; Europe"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/","name":"Robots Take Over | Susanna Koelblin | LinkedIn - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#primaryimage"},"thumbnailUrl":"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg","datePublished":"2017-04-06T05:03:43+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#primaryimage","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg?fit=2000%2C1125&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2017\/04\/aaeaaqaaaaaaaa0maaaajdcwnmu1ngyzltnmnzmtndrjzi04ztm4lwrkzde4zmy5ntzinw.jpg?fit=2000%2C1125&ssl=1","width":2000,"height":1125},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2017\/04\/06\/robots-take-over-susanna-koelblin-linkedin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Robots Take Over | Susanna Koelblin | LinkedIn"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-3Vz","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":5319,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/08\/22\/germany-backs-draghi-bond-plan-against-bundesbank-telegraph\/","url_meta":{"origin":15101,"position":0},"title":"Germany backs Draghi bond plan against Bundesbank &#8211; Telegraph","author":"Colin Twiggs","date":"August 22, 2012","format":false,"excerpt":"By Ambrose Evans-Pritchard, 9:39PM BST 20 Aug 2012 \u201cA currency can only be stable if its future existence is not in doubt,\u201d said J\u00f6rg Asmussen, the powerful German member of the ECB\u2019s executive board. He signalled full backing for the bond rescue plan of ECB chief Mario Draghi, brushing aside\u2026","rel":"","context":"In &quot;Banks &amp; Interest Rates&quot;","block_context":{"text":"Banks &amp; Interest Rates","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/the-fed-banks-interest-rates\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":25647,"url":"https:\/\/thepatientinvestor.com\/index.php\/2021\/05\/07\/vulcan-energy-vul\/","url_meta":{"origin":15101,"position":1},"title":"Vulcan Energy (VUL)","author":"Colin Twiggs","date":"May 7, 2021","format":false,"excerpt":"Small cap Vulcan Energy (VUL) is generating some excitement. From Autoblog.com: BERLIN \u2014 With an eye on rapidly rising demand from Germany's electric vehicle industry, power and mining companies alike are striving to bring to the surface lithium trapped in underground springs of boiling hot water thousands of meters below\u2026","rel":"","context":"In &quot;Australia &amp; NZ&quot;","block_context":{"text":"Australia &amp; NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1823,"url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/11\/07\/germany-must-do-it-not-china-credit-writedowns\/","url_meta":{"origin":15101,"position":2},"title":"Germany must do it, not China | Credit Writedowns","author":"ColinTwiggs","date":"November 7, 2011","format":false,"excerpt":"In the end this is Germany\u2019s crisis to resolve, not China\u2019s. Germany has benefited tremendously from the euro. Nearly all of its growth in the past decade can be explained by its rising trade surplus which, given monetary policy driven almost exclusively by the needs of slow-growing and consumption-repressed Germany,\u2026","rel":"","context":"In &quot;UK &amp; Europe&quot;","block_context":{"text":"UK &amp; Europe","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/uk-europe-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":15357,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/05\/26\/germany-dax-retraces\/","url_meta":{"origin":15101,"position":3},"title":"Germany: DAX retraces","author":"ColinTwiggs","date":"May 26, 2017","format":false,"excerpt":"Germany's DAX is retracing to test its new support level at 12400\/12500. Rising Twiggs Money Flow signals long-term buying pressure. Respect of support is likely and would confirm a primary advance, with a target of 13400*. * Target calculation: 12400 + ( 12400 \u2013 11400 ) = 13400","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1870,"url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/11\/11\/economonitor-economonitor-europe-begins-its-endgame-watch-and-learn-for-europes-problems-are-the-worlds\/","url_meta":{"origin":15101,"position":4},"title":"EconoMonitor : EconoMonitor \u00bb Europe Begins Its Endgame. Watch and Learn, for Europe\u2019s Problems Are the World\u2019s.","author":"ColinTwiggs","date":"November 11, 2011","format":false,"excerpt":"The current structure of Europe cracks under the slowly rising stress of vendor financing: export-based prosperity for some, debt-financed consumption by others. Unless reformed, this can only end badly. The global economy has similar imbalances. In 2010 the trade surpluses of China, Russia, and East Asia (China being half the\u2026","rel":"","context":"In &quot;UK &amp; Europe&quot;","block_context":{"text":"UK &amp; Europe","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/uk-europe-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":280,"url":"https:\/\/thepatientinvestor.com\/index.php\/2011\/08\/16\/europe-need-not-wait-for-germany-ft-com\/","url_meta":{"origin":15101,"position":5},"title":"Europe need not wait for Germany &#8211; FT.com","author":"ColinTwiggs","date":"August 16, 2011","format":false,"excerpt":"Replacing all national sovereign bonds (although not loans) with common eurobonds would create a market worth \u20ac5,500bn. It would be backed by governments that together owe less debt, run a lower combined deficit and have greater tax-raising capacity than the US and Japan. It would almost certainly lead to lower\u2026","rel":"","context":"In &quot;UK &amp; Europe&quot;","block_context":{"text":"UK &amp; Europe","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/uk-europe-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/15101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=15101"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/15101\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=15101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=15101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=15101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}